ImmPACT Bio

ImmPACT Bio USA Inc. is a cell therapy company aimed at developing effective and selective engineered T cells for the treatment of solid tumors. It has been incubated in the FutuRx incubator since 2017. The company's technology targets the loss of genetic characteristics in solid tumor cells while preserving normal, healthy tissue.